We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-8.01%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$437M
AUM Growth
-$154M
Cap. Flow
-$278M
Cap. Flow %
-63.62%
Top 10 Hldgs %
85.63%
Holding
469
New
128
Increased
133
Reduced
148
Closed
42
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCII icon
226
LCI Industries
LCII
$2.59B
$11K ﹤0.01%
95
+13
+16% +$1.42K
RCL icon
227
Royal Caribbean
RCL
$86.5B
$11K ﹤0.01%
316
-582
-65% -$36.2K
SPCE icon
228
Virgin Galactic
SPCE
$315M
$11K ﹤0.01%
95
+15
+19% +$2.18K
SWK icon
229
Stanley Black & Decker
SWK
$14.5B
$11K ﹤0.01%
101
-13
-11% -$1.6K
NUVA
230
DELISTED
NuVasive, Inc.
NUVA
$11K ﹤0.01%
222
+119
+116% +$6.38K
TWTR
231
DELISTED
Twitter, Inc.
TWTR
$11K ﹤0.01%
302
-273
-47% -$11.7K
ABNB icon
232
Airbnb
ABNB
$90.8B
$10K ﹤0.01%
117
-41
-26% -$5.34K
PDD icon
233
Pinduoduo
PDD
$126B
$10K ﹤0.01%
154
+37
+32% +$1.73K
MCAE
234
DELISTED
Mountain Crest Acquisition Corp. III Common Stock
MCAE
$10K ﹤0.01%
+1,055
New +$10.4K
MIT
235
DELISTED
Mason Industrial Technology, Inc.
MIT
$10K ﹤0.01%
+1,006
New +$9.83K
THCA
236
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
$10K ﹤0.01%
+1,000
New +$10.7K
ARRY icon
237
Array Technologies
ARRY
$740M
$9K ﹤0.01%
795
+154
+24% +$1.52K
BBIO icon
238
BridgeBio Pharma
BBIO
$16.4B
$9K ﹤0.01%
975
+92
+10% +$769
BURL icon
239
Burlington
BURL
$23.4B
$9K ﹤0.01%
63
+2
+3% +$362
CABO icon
240
Cable One
CABO
$237M
$9K ﹤0.01%
7
TDAY
241
USA Today Co
TDAY
$1.29B
$9K ﹤0.01%
3,118
+159
+5% +$605
NVCR icon
242
NovoCure
NVCR
$1.77B
$9K ﹤0.01%
136
+36
+36% +$2.71K
OPEN icon
243
Opendoor
OPEN
$3.54B
$9K ﹤0.01%
1,975
-98
-5% -$646
SOFI icon
244
SoFi Technologies
SOFI
$19.6B
$9K ﹤0.01%
1,795
-94
-5% -$635
TTWO icon
245
Take-Two Interactive
TTWO
$46.1B
$9K ﹤0.01%
+77
New +$9.8K
TVTX icon
246
Travere Therapeutics
TVTX
$5.17B
$9K ﹤0.01%
388
+354
+1,041% +$8.9K
GBX icon
247
The Greenbrier Companies
GBX
$1.57B
$8K ﹤0.01%
232
-44
-16% -$1.84K
LAZR
248
DELISTED
Luminar Technologies
LAZR
$8K ﹤0.01%
90
+8
+10% +$1.28K
LCID icon
249
Lucid Motors
LCID
$3.11B
$8K ﹤0.01%
47
-97
-67% -$18.4K
MTSI icon
250
MACOM Technology Solutions
MTSI
$17.4B
$8K ﹤0.01%
167
-20
-11% -$1.03K

Similar funds

Elequin Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Elequin Capital held 469 positions worth $437M, down 26% from $590M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Elequin Capital withdrew a net $278M in Q2 2022, closing 42 positions and reducing 148 holdings. Its most notable exit was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, an estimated $453M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 0.03% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Elequin Capital opened a new position in Austerlitz Acquisition Corporation II worth $2.29M.

  • Elequin Capital's largest Q2 2022 buy was Austerlitz Acquisition Corporation II: 235,000 shares worth $2.29M.
  • Elequin Capital added most to Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2022, an estimated $164M increase.
  • Elequin Capital's biggest Q2 2022 reduction was Aptiv, cutting an estimated $1.04M.
  • Elequin Capital fully exited Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q2 2022, selling an estimated $453M.
  • Elequin Capital's ten largest holdings make up 86% of its $437M portfolio in Q2 2022.
  • Elequin Capital opened 128 new positions and closed 42 in Q2 2022.
  • Elequin Capital's portfolio value fell 26% quarter-over-quarter to $437M.

Based on Elequin Capital's 13F filing for Q2 2022, filed 11 Aug 2022.